The Company of Biologists has announced its latest collaboration, a Read & Publish Open Access agreement with the Indian Institutes of Science Education and Research (IISER) Consortium for 2023.
Under this agreement, corresponding authors affiliated with participating IISER institutions in India will have the opportunity to publish an unlimited number of research articles immediately Open Access (OA) in The Company of Biologists' hybrid journals, including Development, Journal of Cell Science, and Journal of Experimental Biology, as well as their fully Open Access journals, Disease Models & Mechanisms, and Biology Open. The best part is that these authors will not be required to pay any article processing charges (APCs). Furthermore, researchers at the IISER institutions will gain unlimited access to The Company of Biologists' hybrid journals, including complete archives dating back to 1853.
This collaboration between The Company of Biologists and the IISER Consortium marks a significant step toward advancing Open Access publishing in India. It showcases the organizations' shared dedication to supporting researchers and fostering the dissemination of scientific knowledge in the biological and biomedical sciences.
With this Read & Publish agreement, researchers at IISER institutions can continue to contribute ground-breaking research without the financial barriers often associated with Open Access publishing. As the global scientific community embraces Open Access as a catalyst for innovation and collaboration, such partnerships play a vital role in accelerating scientific progress and promoting the free flow of knowledge.
Click here to read the original press release.
